Long COVID will cost the U.S. economy an estimated $8 billion over three years in direct healthcare spending and lost productivity, according to research published by health economists in May 2026.
The study aggregated medical claims, disability filings, and workforce participation data for patients with persistent post-viral symptoms. Researchers found that even patients not hospitalized during acute infection incurred substantial long-term treatment costs.
Employers reported elevated absenteeism and reduced hours among affected workers, particularly in healthcare, education, and logistics sectors. Federal disability programs saw rising applications linked to chronic fatigue and cognitive impairment.
Public health advocates said the figures justify continued funding for Long COVID clinics and clinical trials. Congress has debated but not passed dedicated appropriations, leaving much of the burden on private insurers and state health systems.
Researchers estimated lost wages separately from direct medical spending, using Bureau of Labor Statistics participation rates. Long COVID clinics at major academic medical centers report months-long wait lists. NIH funding for post-acute sequelae research has fluctuated with congressional appropriations cycles. Disability attorneys said approval rates for COVID-related claims remain inconsistent across Social Security field offices.
CDC surveys estimate millions of Americans experience lingering post-COVID symptoms. Employer wellness programs added fatigue management resources in response. Congressional Republicans proposed reducing NIH post-acute research line items in budget drafts debated this month.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://dailycuratednews.substack.com/p/news-headlines-may-22-2026